TenschertEKernJAffolterA, et al.Optimisation of conditions for the formation of spheroids of head and neck squamous cell carcinoma cell lines for use as animal alternatives. Altern Lab Anim2022; 50: 414–422.
2.
MagliaroCAhluwaliaA. Biomedical research on substances of abuse: The Italian case study. Altern Lab Anim2022; 50: 423–436.
3.
AmarasekaraDSRathnadiwakaraHRatnayakeK, et al.The Capability Maturity Model as a measure of culture of care in laboratory animal science. Altern Lab Anim2022; 50: 437–446.
4.
BallsM. ATLA: Trends in replacement and the Three Rs. Altern Lab Anim2022; 50: 10–26.
5.
NeuhausWReininger-GutmannBRinnerB, et al.The rise of Three Rs centres and platforms in Europe. Altern Lab Anim2022; 50: 90–120.
6.
NeuhausWReininger-GutmannBRinnerB, et al.The current status and work of Three Rs centres and platforms in Europe. Altern Lab Anim2022; 50: 381–413.
7.
BraidHR. The use of simulators for teaching practical clinical skills to veterinary students — A review. Altern Lab Anim2022; 50: 184–194.
8.
LandsiedelRBirkBFunk-WeyerD. The evolution of regulatory toxicology: Where is the gardener?Altern Lab Anim2022; 50: 255–262.
9.
SwatersDvan VeenAvan MeursW, et al.A history of regulatory animal testing: What can we learn?Altern Lab Anim2022; 50: 322–329.
